Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi‐institutional propensity score‐matched study

Background and Objectives In the setting of a minimally invasive approach, we aimed to compare short and long‐term postoperative outcomes of patients treated with neoadjuvant therapy (NAT) + surgery or upfront surgery in Western population. Methods All consecutive patients from six Italian and one S...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology Vol. 124; no. 8; pp. 1338 - 1346
Main Authors: Bracale, Umberto, Corcione, Francesco, Pignata, Giusto, Andreuccetti, Jacopo, Dolce, Pasquale, Boni, Luigi, Cassinotti, Elisa, Olmi, Stefano, Uccelli, Matteo, Gualtierotti, Monica, Ferrari, Giovanni, De Martini, Paolo, Bjelović, Miloš, Gunjić, Dragan, Cuccurullo, Diego, Sciuto, Antonio, Pirozzi, Felice, Peltrini, Roberto
Format: Journal Article
Language:English
Published: United States Wiley Subscription Services, Inc 01-12-2021
John Wiley and Sons Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objectives In the setting of a minimally invasive approach, we aimed to compare short and long‐term postoperative outcomes of patients treated with neoadjuvant therapy (NAT) + surgery or upfront surgery in Western population. Methods All consecutive patients from six Italian and one Serbian center with locally advanced gastric cancer who had undergone laparoscopic gastrectomy with D2 lymph node dissection were selected between 2005 and 2019. After propensity score‐matching, postoperative morbidity and oncologic outcomes were investigated. Results After matching, 97 patients were allocated in each cohort with a mean age of 69.4 and 70.5 years. The two groups showed no difference in operative details except for a higher conversion rate in the NAT group (p = 0.038). The overall postoperative complications rate significantly differed between NAT + surgery (38.1%) and US (21.6%) group (p = 0.019). NAT was found to be related to a higher risk of postoperative morbidity in patients older than 60 years old (p = 0.013) but not in patients younger (p = 0.620). Conversely, no difference in overall survival (p = 0.41) and disease‐free‐survival (p = 0.34) was found between groups. Conclusions NAT appears to be related to a higher postoperative complication rate and equivalent oncological outcomes when compared with surgery alone. However, poor short‐term outcomes are more evident in patients over 60 years old receiving NAT.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-4790
1096-9098
1096-9098
DOI:10.1002/jso.26657